BioSpace News Archive

CVS Health Corporation announced that Eva Boratto, Executive Vice President and Chief Financial Officer, and Karen Lynch, Executive Vice President and President of Aetna, will be participating in a fireside chat with investors at the Goldman Sachs 41st Annual Healthcare Conference on June 10, 2020, at approximately 8:00 am ET.

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has been engaged to develop and supply custom quality assessment products (QAPs™) to support the registration and sales of a new point-of-care instrument and its tests for viral respiratory pathogens.

In support of World Hypoparathyroidism Awareness Day, the HypoPARAthyroidism Association (HPA) today released findings of its recent survey highlighting the experiences of patients living with hypoparathyroidism (hypopara or HP) in the United States (U.S.).

Dr. Krishna’s main responsibilities will be to assist and advise Ehave on human trials for its cognitive and psychedelic opportunities.

An emerging surgical technique added to the standard anterior cruciate ligament reconstruction in high-risk adolescent athletes resulted in zero re-tears and zero graft failures after a minimum follow-up of two years, according to preliminary results from patients who were treated at Hospital for Special Surgery.

Additional programs and benefits include relief for patients who have lost dental benefits, support for those accessing preventive care and funding to support dentists with COVID-19 recovery efforts, including personal protective equipment and other costs.

The AI cancer screening startup will use the funding to expand its suite of medical imaging AIs, and launch the Ezra COVID 360 offering.

Sexton Biotechnologies has announced a new solution for biotech manufacturing companies looking for flexible automation options.

The newly named WaveForm Diabetes (formerly AgaMatrix Holdings) welcomes new Executive Chairman and CEO, Rick Valencia, to further the company’s growth and expansion into global markets

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announces its study, along with a collaborative research initiative to expedite project needs during the COVID-19 pandemic